This is a routine insider sale by a director with no executive role. The small size and pattern of periodic sales suggest portfolio diversification rather than a negative signal. No immediate trading action warranted; monitor for any acceleration of insider selling ahead of upcoming catalysts.
Price Chart
Executive Summary
Director William J. Link filed a Form 144 notice of intent to sell 12,500 shares of Tarsus Pharmaceuticals common stock, valued at approximately $776,497. This is a routine, small-scale sale by a non-executive director, representing less than 0.03% of the company's $2.7B market cap. The filing signals no material change in company fundamentals or insider sentiment.
Key Facts
- Director William J. Link (PhD) filed Form 144 to sell 12,500 shares of TARS common stock.
- Estimated sale value: $776,497.54 based on filing date price (~$62.12/share).
- Shares were acquired via stock option exercise on 01/10/2017.
- Sale is planned for on or after 06/15/2026, with Merrill Lynch as broker.
- Link previously sold 12,500 shares on 03/16/2026 for $859,787, indicating periodic diversification.
Financial Impact
Sale of 12,500 shares worth ~$776K, immaterial relative to $2.7B market cap.
Risk Factors
- Insider selling could increase if more directors or executives file similar notices.
- Form 144 is only an intent to sell; the sale may not be executed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-043282 |
| Document: 0001628280-26-043282-index.html | 0001628280-26-043282 |
| Document: 0001628280-26-043282.txt | 0001628280-26-043282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $82.77 $77.64 | ▼ −6.20% | ▼ −5.54% | $73.00 (−11.80%) |
Sep 3, 2026 29d ago | Insider Cluster | $83.21 $79.31 | ▼ −4.68% | ▼ −3.53% | $73.00 (−12.26%) |
Sep 2, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.00 (+11.79%) |
Sep 1, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $73.00 (+11.79%) |
Aug 19, 2026 6w ago | 144 | $73.44 $70.65 | ▼ −3.80% | ▼ −3.41% | $73.00 (−0.60%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $73.00 (+11.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access